Financial capacity in persons with schizophrenia and serious mental illness: Clinical and research ethics aspects

Schizophrenia Bulletin

Volumn 32, Issue 1, 2006, Pages 81-91

  Marson, Daniel C ^a,b,d   Savage, Robert ^c   Phillips, Jacqueline ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d The University of Alabama at Birmingham   (United States)

Author keywords

Ethics; Financial capacity; Representative payee; Schizophrenia; SMI

Indexed keywords

CLINICAL PRACTICE; COMMUNITY; ETHICS; FAMILY; FINANCIAL MANAGEMENT; INFORMED CONSENT; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE PERSONNEL; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; SCHIZOPHRENIA;

BIOMEDICAL RESEARCH; FINANCING, PERSONAL; HUMANS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 30344456696     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbj027     Document Type: Review

References (57)

1. Carpenter W, Gold J, Lahti A, Queern C, Conley R, Bartko J, Kovnick J, Appelbaum P. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57:533-538.
2. Green M. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
3. Grisso T, Appelbaum P. Mentally ill and non-mentally ill patients' abilities to understand informed consent disclosure for medication. Law Hum Behav. 1991;15:377-388.
4. Klapow J, Evans J, Patterson T, Heaton R, Koch W, Jeste D. Direct assessment of functional status in older patients with schizophrenia. Am J Psychiatry. 1997;154(7):1022-1024.
5. Cohen B, McGarvey E, Pinkerton R, Kryzhanivska L. Willingness and competence of depressed and schizophrenic patients to consent to research. J Am Acad Psychiatry Law. 2004;32(2).
6. Grisso T, Appelbaum P. The MacArthur Treatment Competence Study. III. abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav. 1995;19:149-169.
7. Vollman J, Bauer A, Danker-Hopfe H, Helmchen H. Competence of mentally ill patients: a comparative empirical study. Psychol Med. 2003;33:1463-1471.
8. National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders That May Affect Decision Making Capacity: Government Printing Office; 1998.
9. Roberts L, Warner T, Nguyen K, Geppert C, Rogers M, Roberts B. Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation. Psychopharmacology. 2003;171:58-67.
10. Appelbaum P, Grisso T. The MacArthur Treatment Competence Study. I. mental illness and competence to consent to treatment. Law Hum Behav. 1995;19:105-126.
11. Dunn L, Jeste D. Problem areas in the understanding of informed consent for research: study of middle-aged and older patients with psychotic disorders. Psychopharmacology. 2003;171:81-85.
12. Roberts L, Warner T, Anderson C, Smithpeter M, Rogers M. Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing. Schizophr Res. 2004;67:283-291.
13. Stroup S, Appelbaum P. The subject advocate: protecting the interests of participants with fluctuating decisionmaking capacity. IRB: Ethics and Human Research. 2003;25(3):9-11.
14. Moye J. Theoretical frameworks for competency in cognitively impaired elderly adults. Journal of Aging Studies. 1996;10:27-42.
15. Marson D, Sawrie S, Snyder S, et al. Assessing financial capacity in patients with Alzheimer disease. Arch Neurol. 2000;57:877-884.
16. Melton G, Petrila J, Poythress N, Slobogin C. Psychological Evaluations for the Courts. New York: Guilford Press; 1987.
17. Marson D. Loss of financial competency in dementia: conceptual and empirical approaches. Aging, Neuropsychology, and Cognition. 2001;8:164-181.
18. Frank J, Degan D. Conservatorship for the chronically mentally ill: review and case series. Int J Law Psychiatry. 1997;20:97-111.
19. Rosen M, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C. Veterans who may need a payee to prevent misuse of funds for drugs. Psychiatr Serv. 2002;53:995-1000.
20. Shaner A, Eckman T, Roberts L, Wilkens J, Tucker D, Tsuang J, Mintz J. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers: a government-sponsored revolving door? N Engl J Med. 1995;333:777-783.
21. Grossman L, Willler J, Miller N, Stovall J, McRae S, Maxwell S. Temporal patterns of veterans' psychiatric service utilization, disability payments, and cocaine use. J Psychoactive Drugs. 1997;29:285-290.
22. Rosen M, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C. Substance abuse and the need for money management assistance among psychiatric inpatients. Drug Alcohol Depend. 2002;67:331-334.
23. Hatfield A. The family as partner in the treatment of mental illness. Hospital and Community Psychiatry. 1979;30:338-340.
24. Patterson T, Goldman S, McKibbon C, Hughes T, Jeste D. UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27:235-245.
25. Dixon L, Turner J, Kruass N, Scott J, McNary S. Case managers' and clients' perspectives on a representative payee program. Psychiatr Serv. 1999;50:781-786.
26. Marson D, Briggs S. Assessing competency in Alzheimer's disease: treatment consent capacity and financial capacity. In: Gauthier S, Cummings JL, eds. Alzheimer's Disease and Related Disorders Annual 2001. London: Martin Dunitz Ltd.; 2001.
27. Earnst K, Wadley V, Aldridge T, Steenwyk A, Hammond A, Harrell L, Marson D. Loss of financial capacity in Alzheimer's disease: the role of working memory. Aging, Neuropsychology, and Cognition. 2001;8:109-119.
28. Grisso T. Evaluating Competencies: Forensic Assessments and Instruments. New York, NY: Plenum Press, 1986.
29. Mahurin R, DeBettignies B, Pirozzolo F. Structured assessment of independent living skills: preliminary report of a performance measure of functional abilities in dementia. J Gerontol B Psychol Sci Soc Sci. 1991;46:58-66.
30. Loewenstein D, Amigo E, Duara R, et al. A new scale for the assessment of functional status in Alzheimer's disease and related disorders. J Gerontol B Psychol Sci Soc Sci. 1989;44:114-121.
31. Marson DC, Harrell LE. Decision making capacity: in reply. Arch Neurol. 1996;53:589-590.
32. Green M, Kern R, Braff D, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000;26:119-136.
33. Hoff A, Kremen W. Neuropsychology in schizophrenia: an update. Current Opinions in Psychiatry. 2003;16:149-155.
34. Elbogen E, Soriano C, Van Dorn R, Swartz M, Swanson J. Consumer views of representative payee use of disability funds to leverage treatment adherence. Psychiatr Serv. 2005;56:45-49.
35. Rosen M, Rosenheck R. Substance use and assignment of representative payees. Psychiatr Serv. 1999;50:95-98.
36. Beuchamp T, Childress J. Principles of Biomedical Ethics. New York: Oxford University Press; 2001.
37. Luchins D, Roberts D, Hanrahan P. Representative payee-ship and mental illness: a review. Adm Policy Ment Health. 2003;30:341-353.
38. Morris J. Conflicts of interest: research and clinical care. Alzheimer's Disease and Associated Disorders. 1994;8:49-57.
39. Torrey E. Surviving Schizophrenia. New York: Harper and Row; 1988.
40. Moye J. Guardianship and conservatorship. In: Grisso T, ed. Evaluating Competencies: Forensic Assessments and Instruments. New York, NY: Plenum Press; 2003;309-390.
41. Luchins D, Hanrahan P, Conrad K, Savage C, Matters M, Shinderman M. An agency-based representative payee program and improved community tenure of persons with mental illness. Psychiatr Serv. 1998;49:183-192.
42. Hanrahan P, Luchins D, Savage C, Patrick G, Roberts D, Conrad K. Representative payee programs for mentally ill persons in Illinois: Census survey. Psychiatr Serv. 2002;53:190-194.
43. Grisso T. Competence to consent to treatment. In: Grisso T, ed. Evaluating Competencies. New York: Kluwer Academic/Plenum Publishers. 2003:391-460.
44. Grisso T. Evaluating Competencies: Forensic Assessments and Instruments. New York: Kluwer Academic/Plenum Publishers; 2003.
45. Grisso T, Appelbaum P, Mulvey E, Fletcher K. The MacArthur Treatment Competence Study. II. measures of abilities related to competence to consent to treatment. Law Hum Behav. 1995;19:127-148.
46. Kim S, Caine E, Currier G, Leibovici A, Ryan M. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158:712-717.
47. Luchins D, Roberts D, Hanrahan P. Provision of protective payee status: a guideline developed for the Behavioral Health Recovery Management Project, University of Chicago; 2004.
48. Social Security Administration. Final report of the representative payment advisory committee; 1996.
49. Social Security Administration. Representative payee abuse: Office of the Inspector General; 2005.
50. Rosenheck R, Lam J, Randolph F. Impact of representative payees on substance abuse by homeless persons with serious mental illness. Psychiatr Serv. 1997;48:800-806.
51. Stoner M. Money management services for the homeless mentally ill. Hospital and Community Psychiatry. 1989;40:751-753.
52. Kagle J, Giebelhausen P. Dual relationships and professional boundaries. Soc Work. 1994;39:213-220.
53. Dresser R. Mentally disabled research subjects: the enduring policy issue. JAMA. 1996;276:67-72.
54. Bently J, Thacker P. The influence of risk and monetary payment on the research decision making process. J Med Ethics. 2004;30:293-298.
55. Grady C. Payment of clinical research subjects. J Clin Invest. 2005;115:1681-1687.
56. Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136:368-373.
57. National Alliance for the Mentally Ill. Public Policy Platform, NAMI Public Policy Committee of the Board of Directors, 7th Ed., 24-27; 2004.